home · filing · 0001437749-24-022636
8-K filed July 12, 2024, 7:59 PM ET
ticker EHSI
CIK 0001089815
leadership
confidence high
sentiment neutral
materiality 0.65
U.S. Neurosurgical Holdings names Dr. Prasad Jeereddi CEO; expands private placement to $5M
Elite Health Systems Inc.
Charles H. Merriman resigned from the Board effective July 10, 2024; no disagreement cited.
Alan Gold resigned as President effective July 10, 2024, but remains on the Board.
Dr. Prasad A. Jeereddi appointed CEO, non-executive director, and Chairman, effective July 10, 2024.
Private placement terms amended to raise up to $5M; ~$2.8M raised to date at $0.50/share.
Executive movements
Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements .
Effective 2024-07-10
Filed July 12, 2024, 7:59 PM ET
the Board unanimously appointed Dr. Prasad A. Jeereddi, age 76, Chief Executive Officer of the Company
Effective 2024-07-10
Filed July 12, 2024, 7:59 PM ET
Mr. Alan Gold resigned from his positions as President of the Company, effective immediately.
Effective 2024-07-10
Filed July 12, 2024, 7:59 PM ET
Mr. Charles H. Merriman resigned from his position as a member of the Board and from all of its committees.
Key facts
Extracted from this filing and checked against the source text.
Executive change
SEC 8-K Item 5.02
confidence 0.95
Dr. Prasad A. Jeereddi was appointed as Chief Executive Officer at Elite Health Systems Inc..
Action appointed
Role Chief Executive Officer
Exact text from the filing
the Board unanimously appointed Dr. Prasad A. Jeereddi, age 76, Chief Executive Officer of the Company
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Alan Gold resigned as President at Elite Health Systems Inc..
Action resigned
Role President
Exact text from the filing
Mr. Alan Gold resigned from his positions as President of the Company, effective immediately.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Charles H. Merriman resigned as Director at Elite Health Systems Inc..
Action resigned
Role Director
Exact text from the filing
Mr. Charles H. Merriman resigned from his position as a member of the Board and from all of its committees.
View on SEC.gov
Source: SEC EDGAR
accession 0001437749-24-022636
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.